Proteon Therapeutics Inc. (PRTO)

0.26
NASDAQ : Health Technology
Prev Close 0.26
Day Low/High 0.25 / 0.26
52 Wk Low/High 0.24 / 3.94
Avg Volume 417.50K
Exchange NASDAQ
Shares Outstanding 19.59M
Market Cap 5.06M
EPS -1.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

PRTO Crosses Above Average Analyst Target

PRTO Crosses Above Average Analyst Target

In recent trading, shares of Proteon Therapeutics Inc have crossed above the average analyst 12-month target price of $2.43, changing hands for $2.45/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Proteon Therapeutics Completes Enrollment In PATENCY-2, Phase 3 Clinical Trial Of Investigational Vonapanitase

Proteon Therapeutics Completes Enrollment In PATENCY-2, Phase 3 Clinical Trial Of Investigational Vonapanitase

- Top-line data from PATENCY-2 expected in March of 2019 -

PRTO Crosses Above Average Analyst Target

PRTO Crosses Above Average Analyst Target

In recent trading, shares of Proteon Therapeutics Inc have crossed above the average analyst 12-month target price of $2.43, changing hands for $2.50/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Proteon Therapeutics Announces $22.0 Million Private Placement

Provides Sufficient Cash into Q4 2019

Biotech Movers: Depomed Shares Tank After Losses Get Even Worse

Biotech Movers: Depomed Shares Tank After Losses Get Even Worse

Depomed unveiled steps the company is taking to shore itself up.

These 5 Stocks Under $10 Could Make You a Lot of Money

These 5 Stocks Under $10 Could Make You a Lot of Money

Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.